Published date: 13 October 2022

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 15 November 2022, 11:59pm

Contract summary

Industry

  • Laboratory, optical and precision equipments (excl. glasses) - 38000000

  • Installation services of laboratory equipment - 51430000

Location of contract

England

Value of contract

£660,000

Procurement reference

NCL001-DN637330-25849174

Published date

13 October 2022

Closing date

15 November 2022

Closing time

11:59pm

Contract start date

22 November 2022

Contract end date

23 November 2027

Contract type

Supply contract

Procedure type

Open procedure

Any interested supplier may submit a tender in response to an opportunity notice.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No


Description

The Faculty of Medical Sciences (FMS) within Newcastle University conducts significant discovery and clinical research on human tissue (healthy and diseased) as well as tissues from other relevant biological models. As part of an MRC equipment award (potential), the University are seeking to purchase a technology that can measure multiple protein biomarkers on various tissues and cellular samples with single cell spatial resolution. Due to the sheer nature and complexity of the biological/clinical questions, the system must be able to detect a minimum of 150 protein biomarkers on the same tissue/cell sample. Such a platform will underpin existing work by the FMS core technology platforms including flow cytometry, Bio-imaging and single cell technologies.

As stated in the above background section, but to reiterate, this tender process is for an
analysis platform that is able to detect and measure over 100 protein biomarkers with single-cell level spatial and morphometric resolution in various tissue sections (fixed/frozen and formalin-fixed paraffin embedded - FFPE- samples) as well as immobilised suspension/adherent primary cells and cell lines. The system should be easy to use with set up and walk away features and be able to utilise a range of freely available reagents from various competitive suppliers. It should also be able to be operated in a high-throughput manner with options for multi-slide loading and automated staining/imaging as one unit. The system must also come with dedicated data analysis options to include single cell segmentation, phenotypic exploration and spatial mapping. The system will be operated and supported by the Newcastle Flow Cytometry and Single cell analysis core facility team as a collaboration with the Bio-Imaging Unit. As part of the offer, we are seeking on-site training for a minimum of three people in all aspects of the platform's operation, including any associated data analysis packages. The offer must include the specified warranty, service and maintenance cover specified in Section 3.2. Please note that the University reserves the right not to make an award of contract. Notification from the MRC about the award of grant funding for the purchase of the platform will be confirmed at the beginning of November. To meet the MRC requirement for delivery, installation and payment the tender process will begin before funding is confirmed.


About the buyer

Contact name

Emma Barksby

Address

Newcastle University
Procurement Services, Kingsgate
Newcastle
NE1 7RU
England

Telephone

+44 1912086298

Email

emma.barksby@ncl.ac.uk

Website

https://www.ncl.ac.uk